Skip to main navigation Skip to search Skip to main content

In Vivo Treatment with Insulin-like Growth Factor 1 Reduces CCR5 Expression on Vaccine-Induced Activated CD4+ T-Cells

  • Massimiliano Bissa
  • , Veronica Galli
  • , Luca Schifanella
  • , Monica Vaccari
  • , Mohammad Arif Rahman
  • , Giacomo Gorini
  • , Nicolò Binello
  • , Sarkis Sarkis
  • , Anna Gutowska
  • , Isabela Silva de Castro
  • , Melvin N. Doster
  • , Ramona Moles
  • , Guido Ferrari
  • , Xiaoying Shen
  • , Georgia D. Tomaras
  • , David C. Montefiori
  • , Kombo F. N’guessan
  • , Dominic Paquin-Proulx
  • , Pamela A. Kozlowski
  • , David J. Venzon
    • Hyoyoung Choo-Wosoba, Matthew W. Breed, Joshua Kramer, Genoveffa Franchini
  • National Institutes of Health
  • Tulane University
  • Duke University
  • Walter Reed Army Institute of Research
  • Henry M. Jackson Foundation
  • Louisiana State University Health Sciences Center
  • Frederick National Laboratory

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'In Vivo Treatment with Insulin-like Growth Factor 1 Reduces CCR5 Expression on Vaccine-Induced Activated CD4+ T-Cells'. Together they form a unique fingerprint.
Sort by

Immunology and Microbiology